col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


124 Results       Page 1

 [1] 
Elsevier: Life Sciences
  original article Date Title Authors   All Authors
1 [GO] 2024―Sep―04 Sex-related differences concerning the profile and evolution of cardiovascular complications in patients with post-acute COVID-19 syndrome Cristina Tudoran, Mariana Tudoran, Ahmed Abu-Awwad, Simona-Alina Abu-Awwad, Cosmin Faur, Mihaela Crisan-Vida, et al. (+2)
2 [GO] 2024―Aug―28 COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review M Vinutha, Uday Raj Sharma, Gurubasvaraja Swamy, S Rohini, Surendra Vada, Suresh Janandri, et al. (+5)
3 [GO] 2024―Aug―13 Designing and optimizing clinical trials for long COVID Julia Moore Vogel, Beth Pollack, Ezra Spier, Lisa McCorkell, Toni Wall Jaudon, Megan Fitzgerald, et al. (+2)
4 [GO] 2024―Aug―12 A practical framework for long COVID treatment in primary care W. Michael Brode, Esther Melamed
5 [GO] 2024―Aug―03 Using real-world data to accelerate the search for long COVID therapies Shira R. Strongin, Elisabeth Stelson, Letícia Soares, Vidula Sukhatme, Pamela Dasher, Marco Schito, et al. (+3)
6 [GO] 2024―Jul―29 Understanding the mechanisms and treatments of long COVID to address future public health risks Bohao Li, Junlu Bai, Yan Xiong, Dong Guo, Beibei Fu, Guohong Deng, Haibo Wu
7 [GO] 2024―Jul―08 Diminazene aceturate inhibits the SARS-CoV-2 spike protein-induced inflammation involving leukocyte migration and DNA extracellular traps formation Gean C. Pereira-Silva, Cassia K.C.A. Cornélio, Gabriella Pacheco, Natalia C. Rochael, Isaac A.B. Gomes, Aurilene G. Cajado, et al. (+13)
8 [GO] 2024―Jun―24 COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, Md. Reyad-ul-Ferdous, Can Yang Zhang, Dongmei Yu, et al. (+6)
9 [GO] 2024―Jun―05 Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics Hugo Massami Endo, Shelon Cristina Souza Bandeca, Luiz Ricardo Olchanheski, Zelinda Schemczssen-Graeff, Marcos Pileggi
10 [GO] 2024―Jun―03 Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy Ming-Shou Hsieh, Ming-Yao Chen, Yu-Sheng Chang, Chin-Sheng Huang, Tung-Nien Hsu, Mao-Suan Huang, et al. (+2)
11 [GO] 2024―Feb―24 The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review Mahmoud Yousef, Mlaak Rob, Sanish Varghese, Shrinidhi Rao, Fahad Zamir, Pradipta Paul, Ali Chaari
12 [GO] 2023―Nov―27 Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM) José María Mora-Rodríguez, Belén G. Sánchez, Alicia Bort, Alba Díaz-Yuste, Rubén Ballester-González, Francisco Arrieta, et al. (+2)
13 [GO] 2023―Oct―01 Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection Kawisara Krasaewes, Romanee Chaiwarith, Nipon Chattipakorn, Siriporn C. Chattipakorn
14 [GO] 2023―Jul―12 Pattern-recognition receptors (PRRs) in SARS-CoV-2 Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, Reza Mohammadinasab, Navid Shomali, Hadi Nasiri, et al. (+5)
15 [GO] 2023―Jun―30 Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, Reza Ahmadi, Mohammad Ghorbani, Mohammad Reza Mansoorian, et al. (+4)
16 [GO] 2023―May―02 Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice Celso M. Queiroz-Junior, Anna C.P.M. Santos, Matheus R. Gonçalves, Camila B. Brito, Breno Barrioni, Pedro J. Almeida, et al. (+7)
17 [GO] 2023―Mar―11 Anti-cancer effect of COVID-19 vaccines in mice models Negar Deldadeh, Shahpar Haghighat, Zahra Omidi, Ramin Sarrami-Foroushani, Alireza Madjid Ansari, Hassan Sanati, et al. (+5)
18 [GO] 2023―Feb―27 Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, Esma Karahmet Farhat, Emma Pinjić, Farooq Sher
19 [GO] 2023―Feb―24 Enhancement of immunogenicity and neutralizing responses against SARS-CoV-2 spike protein using the Fc fusion fragment Yahya Ehteshaminia, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Seyed Ehsan Enderami, Abdol Sattar Pagheh, Esmaeil Akbari, et al. (+2)
20 [GO] 2023―Jan―06 Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development Feng Lin, Xiaoyuan Lin, Beibei Fu, Yan Xiong, Mohamed Y. Zaky, Haibo Wu
21 [GO] 2022―Sep―29 Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality Aneta Aleksova, Alessandra Lucia Fluca, Giulia Gagno, Alessandro Pierri, Laura Padoan, Agnese Derin, et al. (+9)
22 [GO] 2022―Sep―21 SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response Pi-Ching Hsu, Md. Shahed-Al-Mahmud
23 [GO] 2022―Sep―06 SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression Cynthia Silva Bartolomeo, Robertha Mariana Rodrigues Lemes, Rafael Leite Morais, Gabriela Cruz Pereria, Tamires Alves Nunes, Angelica Jardim Costa, et al. (+9)
24 [GO] 2022―Aug―24 Vitamin D modulates systemic inflammation in patients with severe COVID-19 Fatemeh Saheb Sharif-Askari, Shirin Hafezi, Narjes Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Bushra Mdkhana, Balachandar Selvakumar, et al. (+4)
25 [GO] 2022―Aug―06 Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19 Azam Hosseinzadeh, Abolfazl Bagherifard, Fereshteh Koosha, Shiva Amiri, Arman Karimi-Behnagh, Russel J. Reiter, Saeed Mehrzadi
26 [GO] 2022―Jul―13 Recent clinical findings on the role of kinase inhibitors in COVID-19 management Zahra Malekinejad, Amir Baghbanzadeh, Ailar Nakhlband, Behzad Baradaran, Sevda Jafai, Yasin Bagheri, et al. (+3)
27 [GO] 2022―Jun―11 SARS-CoV-2-infection induced growth factors play differential roles in COVID-19 pathogenesis Anamika Gupta, Manju N. Jayakumar, Mohamed A. Saleh, Meganathan Kannan, Rabih Halwani, Rizwan Qaisar, Firdos Ahmad
28 [GO] 2022―May―11 Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein Maria Fernanda Fernandes, John Zewen Chan, Chia Chun Joey Hung, Michelle Victoria Tomczewski, Robin Elaine Duncan
29 [GO] 2022―Mar―11 Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19 Zakiye Nadeali, Fatemeh Mohammad Rezaei, Hamid Aria, Parvaneh Nikpour
30 [GO] 2022―Mar―07 COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent Sebastián García Menéndez, Virna Margarita Martín Giménez, Michael F. Holick, Francisco J. Barrantes, Walter Manucha
31 [GO] 2022―Feb―16 Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions Anant Narayan Bhatt, Abhishek Kumar, Yogesh Rai, Neeraj Kumari, Dhiviya Vedagiri, Krishnan H. Harshan, et al. (+2)
32 [GO] 2022―Feb―08 The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19 Nafiseh Saghafi, Seyed Abdolrahim Rezaee, Amir Abbas Momtazi-Borojeni, Fataneh Tavasolian, Thozhukat Sathyapalan, Elham Abdollahi, Amirhossein Sahebkar
33 [GO] 2022―Jan―30 Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality Dun-Xian Tan, Russel J. Reiter
34 [GO] 2022―Jan―14 ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors Andrea Estefanía Portales, Emilio Román Mustafá, Clara Inés McCarthy, María Paula Cornejo, Paula Monserrat Couto, Mariela Mercedes Gironacci, et al. (+3)
35 [GO] 2021―Oct―20 The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy Suhana Ahmad, Ma'mon M. Hatmal, Lidawani Lambuk, Mohammad A.I. Al-Hatamleh, Walhan Alshaer, Rohimah Mohamud
36 [GO] 2021―Aug―25 Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope Deeksha Pal, Jyoti Goyal, Ujjawal Sharma, Aman Sharma, Saurabh Prashar, Garima Rathi, et al. (+2)
37 [GO] 2021―Aug―10 In-vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice Narayanappa Amruta, Elizabeth B. Engler-Chiurazzi, Isabel C. Murray-Brown, Timothy E. Gressett, Ifechukwude J. Biose, Wesley H. Chastain, et al. (+2)
38 [GO] 2021―May―18 Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study Emre Karsli, Ramazan Sabirli, Emel Altintas, Omer Canacik, Gizem Tukenmez Sabirli, Buse Kaymaz, et al. (+2)
39 [GO] 2021―May―12 Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha
40 [GO] 2021―May―10 Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19 Hamza Malik Okuyan, Serdar Dogan, Tayibe Bal, Mehmet Çabalak
41 [GO] 2021―Apr―16 Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19 Gustavo C. Paris, Aline de A. Azevedo, Adriana L. Ferreira, Yanca M. de A. Azevedo, Mateus A. Rainho, Genilza P. de Oliveira, et al. (+6)
42 [GO] 2021―Apr―16 Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2 Mahnaz Ghaebi, Safa Tahmasebi, Maryam Jozghorbani, Alireza Sadeghi, Lakshmi Thangavelu, Angelina Olegovna Zekiy, Abdolreza Esmaeilzadeh
43 [GO] 2021―Mar―28 Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2 Safa Tahmasebi, Balsam Qubais Saeed, Elmira Temirgalieva, Alexei Valerievich Yumashev, Mohamed A. El-Esawi, Jamshid Gholizadeh Navashenaq, et al. (+8)
44 [GO] 2021―Mar―27 Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients Simone R. Potje, Tiago J. Costa, Thais F.C. Fraga-Silva, Ronaldo B. Martins, Maira N. Benatti, Carlos E.L. Almado, et al. (+9)
45 [GO] 2021―Mar―24 Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity Rosalinda Posadas-Sánchez, Fausto Sánchez-Muñoz, Carlos Alfonso Guzmán Martin, Adrian Hernández-Díaz Couder, Gustavo Rojas-Velasco, José Manuel Fragoso, Gilberto Vargas-Alarcón
46 [GO] 2021―Mar―19 Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study Xueqi Cheng, Siyi Xin, Yaqi Chen, Leyu Li, Wanjun Chen, Wenjia Li, et al. (+6)
47 [GO] 2021―Mar―12 Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review Elizabeth Dimbath, Veeranna Maddipati, Jennifer Stahl, Kerry Sewell, Zachary Domire, Stephanie George, Ali Vahdati
48 [GO] 2021―Mar―05 The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing Parichehr Hassanzadeh
49 [GO] 2021―Feb―23 Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives Sara Chiappalupi, Laura Salvadori, Aleksandra Vukasinovic, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi
50 [GO] 2021―Feb―17 COVID-19, cytokines, inflammation, and spices: How are they related? Ajaikumar B. Kunnumakkara, Varsha Rana, Dey Parama, Kishore Banik, Sosmitha Girisa, Henamayee Sahu, et al. (+5)
51 [GO] 2021―Feb―17 A double edged-sword - The Complement System during SARS-CoV-2 infection Lazara Elena Santiesteban-Lores, Thais Akemi Amamura, Tiago Francisco da Silva, Leonardo Moura Midon, Milena Carvalho Carneiro, Lourdes Isaac, Lorena Bavia
52 [GO] 2021―Feb―09 Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing Ricardo Savirón-Cornudella, Ana Villalba, Luis M. Esteban, Mauricio Tajada, Belén Rodríguez-Solanilla, Mercedes Andeyro-Garcia, et al. (+4)
53 [GO] 2021―Jan―27 SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis Parisa Shiri Aghbash, Narges Eslami, Ali Shamekh, Taher Entezari-Maleki, Hossein Bannazadeh Baghi
54 [GO] 2021―Jan―26 Biosensors as a future diagnostic approach for COVID-19 Suhad Abbas Abid, Ahmed Suhail, Israa M.S. Al-Kadmy, Anas A. Sattar, Amany Magdy Beshbishy, Gaber El-Saber Batiha, Helal F. Hetta
55 [GO] 2021―Jan―26 Cardiovascular protective properties of oxytocin against COVID-19 Stephani C. Wang, Yu-Feng Wang
56 [GO] 2021―Jan―19 Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan Muhammad Fawad, Sumaira Mubarik, Saima Shakil Malik, Jingli Ren
57 [GO] 2021―Jan―15 Monocytes and macrophages in COVID-19: Friends and foes Sepideh Meidaninikjeh, Nasim Sabouni, Hadi Zare Marzouni, Sajad Bengar, Ahmad Khalili, Reza Jafari
58 [GO] 2021―Jan―14 The proteomic characteristics of airway mucus from critical ill COVID-19 patients Zili Zhang, Tao Wang, Fei Liu, Airu Zhu, Guoping Gu, Jieping Luo, et al. (+7)
59 [GO] 2021―Jan―14 Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity Riham Abdel-Hamid Haroun, Waleed H. Osman, Asmaa M. Eessa
60 [GO] 2020―Dec―23 Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu
61 [GO] 2020―Dec―19 DNA vaccines against COVID-19: Perspectives and challenges Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira, Marcelo Mendonça
62 [GO] 2020―Dec―11 Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors P. Krishna Murthy, Karthikeyan Sivashanmugam, Mahesh Kandasamy, Rajasekaran Subbiah, Vilwanathan Ravikumar
63 [GO] 2020―Dec―10 Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro Jiayu Lu, Yajing Hou, Shuai Ge, Xiangjun Wang, Jue Wang, Tian Hu, et al. (+3)
64 [GO] 2020―Nov―19 High GRP78 levels in Covid-19 infection: A case-control study Ramazan Sabirli, Aylin Koseler, Tarik Goren, Ibrahim Turkcuer, Ozgur Kurt
65 [GO] 2020―Oct―28 Is highly expressed ACE 2 in pregnant women “a curse” in times of COVID-19 pandemic? Ankit Dhaundiyal, Puja Kumari, Snehal Sainath Jawalekar, Gaurav Chauhan, Sourav Kalra, Umashanker Navik
66 [GO] 2020―Oct―26 The impact of oxidative stress damage induced by the environmental stressors on COVID-19 Bianza Moise Bakadia, Biaou Oscar Ode Boni, Abeer Ahmed Qaed Ahmed, Guang Yang
67 [GO] 2020―Oct―10 Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics Pooja Yadav, Ravina Vats, Afsareen Bano, Rashmi Bhardwaj
68 [GO] 2020―Oct―06 Involvement of the nervous system in COVID-19: The bell should toll in the brain Sairaj Satarker, Madhavan Nampoothiri
69 [GO] 2020―Oct―06 Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Gerwyn Morris, Eugene Athan, Ken Walder, Chiara C. Bortolasci, Adrienne O'Neil, Wolf Marx, et al. (+4)
70 [GO] 2020―Sep―28 Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19 A. Vitiello, F. Ferrara
71 [GO] 2020―Sep―23 Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action Somaye Sadeghi, Sara Soudi, Abbas Shafiee, Seyed Mahmoud Hashemi
72 [GO] 2020―Sep―21 Cardiac inflammation in COVID-19: Lessons from heart failure Sathya D. Unudurthi, Priya Luthra, Rajendran J.C. Bose, Jason McCarthy, Maria Irene Kontaridis
73 [GO] 2020―Sep―18 Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach Assia Belhassan, Fatima En-nahli, Hanane Zaki, Tahar Lakhlifi, Mohammed Bouachrine
74 [GO] 2020―Sep―15 SARS-CoV-2 and coagulation disorders in different organs Sathishkumar Vinayagam, Kamaraj Sattu
75 [GO] 2020―Sep―11 New insight on possible vaccine development against SARS-CoV-2 Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, et al. (+4)
76 [GO] 2020―Sep―09 Parameters predicting COVID-19-induced myocardial injury and mortality G.D. Duerr, A. Heine, M. Hamiko, S. Zimmer, J.A. Luetkens, J. Nattermann, et al. (+13)
77 [GO] 2020―Aug―23 Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19 Antony Cheudjeu
78 [GO] 2020―Aug―23 Attaching clinical significance to COVID-19-associated diarrhea Fantao Wang, Shiliang Zheng, Chengbin Zheng, Xiaodong Sun
79 [GO] 2020―Aug―23 COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic Valamla Bhavana, Pradip Thakor, Shashi Bala Singh, Neelesh Kumar Mehra
80 [GO] 2020―Aug―21 Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies Gilberto Vargas-Alarcón, Rosalinda Posadas-Sánchez, Julian Ramírez-Bello
81 [GO] 2020―Aug―17 Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges Vineela Parvathaneni, Vivek Gupta
82 [GO] 2020―Aug―08 Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study Faezeh Sadat Hosseini, Massoud Amanlou
83 [GO] 2020―Aug―07 Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review Saniya Mahendiratta, Gitika Batra, Phulen Sarma, Harish Kumar, Seema Bansal, Subodh Kumar, et al. (+3)
84 [GO] 2020―Aug―03 Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review Subham Das, K.R. Anu, Sumit Raosaheb Birangal, Ajinkya Nitin Nikam, Abhijeet Pandey, Srinivas Mutalik, Alex Joseph
85 [GO] 2020―Aug―01 The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19 Amir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
86 [GO] 2020―Jul―31 The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Lisa Olive, Wolfgang Marx, Adrienne O'Neil, et al. (+5)
87 [GO] 2020―Jul―29 The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis Hamed Akbari, Reza Tabrizi, Kamran B. Lankarani, Hamid Aria, Sina Vakili, Fatemeh Asadian, et al. (+3)
88 [GO] 2020―Jul―29 Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13 Burcu Biterge Süt
89 [GO] 2020―Jul―29 Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2 Kedar Sharma, Sudhir Morla, Arun Goyal, Sachin Kumar
90 [GO] 2020―Jul―24 The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future Jishou Zhang, Menglong Wang, Wen Ding, Jun Wan
91 [GO] 2020―Jul―18 Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions Abdollah Jafarzadeh, Prashant Chauhan, Bhaskar Saha, Sara Jafarzadeh, Maryam Nemati
92 [GO] 2020―Jul―18 Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation Alireza Paniri, Haleh Akhavan-Niaki
93 [GO] 2020―Jul―17 An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic Sumit Jamwal, Akash Gautam, John Elsworth, Mandeep Kumar, Rakesh Chawla, Puneet Kumar
94 [GO] 2020―Jul―15 The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics Mitra Abbasifard, Hossein Khorramdelazad
95 [GO] 2020―Jul―15 Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis Suvojit Hazra, Alok Ghosh Chaudhuri, Basant K. Tiwary, Nilkanta Chakrabarti
96 [GO] 2020―Jul―12 Tackling the cytokine storm in COVID-19, challenges, and hopes Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar
97 [GO] 2020―Jul―10 The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions Tapan Behl, Ishnoor Kaur, Simona Bungau, Arun Kumar, Md Sahab Uddin, Chanchal Kumar, et al. (+4)
98 [GO] 2020―Jul―09 Update on neurological manifestations of COVID-19 Hanie Yavarpour-Bali, Maryam Ghasemi-Kasman
99 [GO] 2020―Jul―09 Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges Mahsa Hajivalili, Maryam Hosseini, Mostafa Haji-Fatahaliha
100 [GO] 2020―Jul―09 Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations Shiv Bharadwaj, Kyung Eun Lee, Vivek Dhar Dwivedi, Sang Gu Kang
101 [GO] 2020―Jul―06 Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination Ariane Sternberg, Cord Naujokat
102 [GO] 2020―Jun―15 Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug Claudia Guadalupe Benítez-Cardoza, José Luis Vique-Sánchez
103 [GO] 2020―Jun―12 Vaccination strategies to combat novel corona virus SARS-CoV-2 Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti, Mukesh Samant
104 [GO] 2020―Jun―11 Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19 Lorane Izabel da Silva Hage-Melim, Leonardo Bruno Federico, Nayana Keyla Seabra de Oliveira, Viviane Cristina Cardoso Francisco, Lenir Cabral Correa, Henrique Barros de Lima, et al. (+4)
105 [GO] 2020―Jun―03 Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Fedor Simko, Russel J. Reiter
106 [GO] 2020―Jun―03 Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, Annie Riera Leal
107 [GO] 2020―Jun―02 The immune system and COVID-19: Friend or foe? Fereshteh Yazdanpanah, Michael R. Hamblin, Nima Rezaei
108 [GO] 2020―Jun―01 Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavraj Shreya, Sadhana P. Mutalik, Divya Gopalan, Sanjay Kulkarni, et al. (+4)
109 [GO] 2020―May―23 Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 Aditi Banerjee, Steven J. Czinn, Russel J. Reiter, Thomas G. Blanchard
110 [GO] 2020―May―22 Coronaviruses pandemics: Can neutralizing antibodies help? Phuoc-Bao-Viet Tong, Li-Yun Lin, Tuan Hiep tran
111 [GO] 2020―May―22 Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review Pureti Lakshmi Prasanna, V.G. Abilash
112 [GO] 2020―May―22 Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi
113 [GO] 2020―May―15 Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment Virna Margarita Martín Giménez, Felipe Inserra, Carlos D. Tajer, Javier Mariani, León Ferder, Russel J. Reiter, Walter Manucha
114 [GO] 2020―May―13 The role of biomarkers in diagnosis of COVID-19 - A systematic review Muhammed Kermali, Raveena Kaur Khalsa, Kiran Pillai, Zahra Ismail, Amer Harky
115 [GO] 2020―May―11 A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials Vaishali M. Patil, Shipra Singhal, Neeraj Masand
116 [GO] 2020―May―08 The current understanding and potential therapeutic options to combat COVID-19 Venkatesh Pooladanda, Sowjanya Thatikonda, Chandraiah Godugu
117 [GO] 2020―Apr―30 Comment on Melatonin as a potential adjuvant treatment for COVID-19 Emilio A. Herrera, Alejandro Gonzalez-Candia
118 [GO] 2020―Apr―29 Myocardial injury and COVID-19: Possible mechanisms Savalan Babapoor-Farrokhran, Deanna Gill, Jackson Walker, Roozbeh Tarighati Rasekhi, Behnam Bozorgnia, Aman Amanullah
119 [GO] 2020―Apr―23 Correspondence COVID-19: Melatonin as a potential adjuvant treatment Cristina Salles
120 [GO] 2020―Apr―10 In silico studies on therapeutic agents for COVID-19: Drug repurposing approach Bhumi Shah, Palmi Modi, Sneha R. Sagar
121 [GO] 2020―Apr―04 Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease Mahmoud Kandeel, Mohammed Al-Nazawi
122 [GO] 2020―Mar―25 Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study Abdo A. Elfiky
123 [GO] 2020―Mar―23 COVID-19: Melatonin as a potential adjuvant treatment Rui Zhang, Xuebin Wang, Leng Ni, Xiao Di, Baitao Ma, Shuai Niu, et al. (+2)
124 [GO] 2020―Feb―28 Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 Abdo A. Elfiky
 [1] 

124 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec